Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
109.20
+4.15 (3.95%)
At close: May 19, 2026, 4:00 PM EDT
109.20
0.00 (0.00%)
After-hours: May 19, 2026, 4:10 PM EDT
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $1.57 billion as of May 19, 2026. Its market cap has increased by 494.43% in one year.
Market Cap
1.57B
Enterprise Value
1.32B
1-Year Change
494.43%
Ranking
Category
Stock Price
$109.20
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $1.57B, an increase of 987.90%. That is a compound annual growth rate of 435.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 1.57B | 26.42% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AtaiBeckley | 1.60B |
| Inhibrx Biosciences | 1.58B |
| Monte Rosa Therapeutics | 1.56B |
| Iovance Biotherapeutics | 1.56B |
| Ardelyx | 1.54B |
| Nuvation Bio | 1.53B |
| Precigen | 1.52B |
| Novavax | 1.52B |